MIAMI (August 20, 2024) – Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional ...

Please provide your email address to receive an email when new articles are posted on . One-time training sessions only provide temporary improvements in technique. Digital technologies may help ...

The researchers noted that their findings highlight the need to understand the challenges in delivering evidence-based care for chronic obstructive pulmonary disease (COPD). Patients who live in rural ...

Please provide your email address to receive an email when new articles are posted on . A Montreal Cognitive Assessment score of 16 or less, which implies dementia, predicted errors in using inhalers.

Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by loss of lung elasticity, which leads to dysfunctional gaseous exchange. COPD is the third leading cause of ...

Patients with chronic obstructive pulmonary disease (COPD) who had cognitive impairment were prone to stop following correct inhaler technique within a month of training, a prospective single-center ...

Medicare Advantage beneficiaries with chronic obstructive pulmonary disease (COPD) who were invited to enroll in a program that reduced inhaler costs and provided medication management had higher ...

A new drug and inhaler combination has received marketing authorisation as a treatment for chronic obstructive pulmonary disease. The European Medicines Agency has approved Almirall’s aclidinium ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy ...

Bulletin: ...WINTER STORM WATCH REMAINS IN EFFECT FROM THIS AFTERNOON THROUGH FRIDAY AFTERNOON... * WHAT...Heavy snow possible. Total accumulations over 6 inches ...

AstraZeneca has completed all clinical studies required to support the first filings for the transition of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri, to a next-generation ...